Factor XI Inhibitors are the alternative to DOACs, which are highly effective at preventing strokes. However, their bleeding risks often limit their use, especially in high-risk patients.

Samples taken by a Swedish team of researchers show how daily coffee drinkers may be at risk of higher cholesterol levels and ...